BioSpace News Archive

Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, announced today it has received data supporting Brilacidin’s direct inhibition of SARS-CoV-2, the novel coronavirus responsible for COVID-19.

Allogene Therapeutics, Inc. today announced that management plans to participate in two upcoming virtual investor conferences. Goldman Sachs Cell Therapy Day Monday, April 6, 2020 9:30 AM PT/12:30 PM ET Canaccord Genuity Horizons in Oncology Conference Wednesday, April 8, 2020 9:45 AM PT/12:45

Corcept Therapeutics Incorporated today announced the publication of an abstract in the April-May supplemental issue of the Journal of the Endocrine Society (JES). The abstract describes the Phase 3 trial (entitled “GRADIENT”) of relacorilant in

Acasti Pharma Inc. (“Acasti” or the “Company”) (NASDAQ: ACST – TSX-V: ACST), a biopharmaceutical innovator focused on the research, development and commercialization of its prescription drug candidate CaPre® (omega-3 phospholipid) for the treatment of severe hypertriglyceridemia, today announced that it has filed its meeting request with the Food and Drug Administration (FDA). The meeting is intended to discuss TRILOGY 1 data, and gain alignm

Aspen Neuroscience, a private biotechnology company developing the first autologous neuron replacement therapy to treat Parkinson disease, today announced the close of its Series A funding round of $70 million.

Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or “the Company”), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, today reported financial results for its full year ended December 31, 2019, as well as select corporate highlights.

Care Bridge International, a data analytics corporation, today announced a new COVID-19 Calculator that estimates the true exposure of medical treatment and costs related to COVID-19 claims

Oramed Pharmaceuticals CEO provided a letter to shareholders

One Medical (Nasdaq: ONEM) announced today the expansion of its virtual care offerings with Remote Visits, scheduled video appointments with a primary care provider, and Mindset by One Medical, a virtual therapy and coaching program to support behavioral health.

Harvest Health & Recreation Inc. (CSE: HARV, OTCQX: HRVSF) (“Harvest”), a vertically integrated cannabis company with one of the largest and deepest footprints in the U.S., today announced that it will hold a conference call on Tuesday, April 7, 2020 at 5:00 PM Eastern Time following the release of its fourth quarter 2019 financial results.